Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Surgical Research

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jss.2012.01.003PMID 22502904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Partially MHC-matched donor CD8+ T cells are indispensable for switching to splenocytic chimerism.

  2012cited by this paper
• Alloantigen specific T regulatory cells in transplant tolerance.

  2009cited by this paper
• Splenocytes Can Replace Chimeric Cells and Maintain Allograft Tolerance

  2007cited by this paper
• Active Role of Chimerism in Transplantation Tolerance Induced by Antilymphocyte Serum, Sirolimus, and Bone–Marrow-Cell Infusion

  2004cited by this paper
• Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation

  2004cited by this paper
• Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

  2003cited by this paper
• Efficacy of donor splenocytes mixed with bone marrow cells for induction of tolerance in sublethally irradiated mice.

  2002cited by this paper
• Allogeneic chimerism established with a mixture of low dose bone marrow cells and splenocytes in sublethally irradiated mice.

  2002cited by this paper
• The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

  2002cited by this paper
• Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation

  2002cited by this paper
• Topoisomerase I Inhibitors with an Indolocarbazole Structure Transporter as a Transporter of NB-506 and J-107088 , Resistance / Placenta-Specific , ATP-binding Cassette Identification of Breast Cancer Resistant Protein / Mitoxantrone Updated

  2001cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• Control of T‐cell activation by CD4+ CD25+ suppressor T cells

  2001cited by this paper
• Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo

  2001cited by this paper
• Dissociation of Hemopoietic Chimerism and Allograft Tolerance After Allogeneic Bone Marrow Transplantation1

  2001cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients

  1999cited by this paper
• A strategy for organ allografts without using immunosuppressants or irradiation.

  1998cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• CD4+ T CELLS, BUT NOT CD8+ T CELLS, MEDIATE THE BREAKING OF TOLERANCE IN MIXED ALLOGENEIC CHIMERAS (B10 + B10.BR ± B10)

  1993cited by this paper
• Cell migration, chimerism, and graft acceptance.

  1992cited by this paper
• Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.

  1992cited by this paper
• Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.

  1991cited by this paper
• MIXED ALLOGENEIC RECONSTITUTION (A+B→A) TO INDUCE DONOR‐SPECIFIC TRANSPLANTATION TOLERANCE: PERMANENT ACCEPTANCE OF A SIMULTANEOUS DONOR SKIN GRAFT

  1991cited by this paper
• Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

  1989cited by this paper
• Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver.

  1969cited by this paper
• ‘Actively Acquired Tolerance’ of Foreign Cells

  1953cited by this paper

• Validation of Donor-Specific Tolerance of Intestinal Transplant by a Secondary Heart Transplantation Model.

  2017cites this paper
• Evidence Based Hepato-Biliary-Pancreatic Surgery in Nihon University

  2016cites this paper
• Inflammatory Mediators in Vascular Disease: Identifying Promising Targets for Intracranial Aneurysm Research

  2015cites this paper
• Spleen Transplantation Model

  2015cites this paper
• Donor‐specific tolerance induction in organ transplantation via mixed splenocytes chimerism

  2013cites this paper
• CD4+CD25+ T regulatory cell-depleted splenocytes enhance chimerism in graft recipients.

  2013cites this paper